• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    10X Genomics Inc (NQ: TXG )

    16.33 +0.30 (+1.87%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about 10X Genomics Inc

    < Previous 1 2 3 4 5 6 7 8 Next >
    10 Health Care Stocks Whale Activity In Today's Session
    This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our... 
    Via Benzinga
    FedEx Options Trade & Stock Analysis
    This week we discuss last week's performance of our trades in the NUGT ETF. We also review our trade of FedEx after recent earnings. 
    Via Talk Markets
    10x Genomics Stock: Bull vs. Bear
    After a hot start, the stock has recently lagged the market. Is now a good time to buy? 
    Via The Motley Fool
    Topics Initial Public Offering
    Exposures Securities Market
    Notable 10X Genomics Insider Trades $2.8M In Company Stock
    Bradford Crutchfield, Insider at 10X Genomics (NASDAQ:TXG), made a large buy and sell of company shares on November 12, according to a new SEC filing. What Happened: A Form 4... 
    Via Benzinga
    Topics Regulatory Compliance
    Exposures Legal Regulatory
    Better Buy: 10x Genomics vs. DermTech
    Both companies offer disruptive new solutions in their niches of the healthcare space. 
    Via The Motley Fool
    The Daily Biotech Pulse: Pfizer, Bristol-Myers Squibb Earnings, Amgen Goes Shopping, GlaxoSmithKline-Vir's COVID-19 Antibody Treatment Supply Deal
    Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 27) Bio-Rad Laboratories, Inc... 
    Via Benzinga
    Exposures COVID-19
    Recap: 10x Genomics Q1 Earnings
    Shares of 10x Genomics (NASDAQ:TXG) remained unaffected after the company reported Q1 results. Quarterly Results Earnings per share rose 186.96% over the past year to $0.66... 
    Via Benzinga
    Chief Executive Officer Of 10X Genomics Trades $2.5M In Company Stock
    Serge Saxonov, Chief Executive Officer at 10X Genomics (NASDAQ:TXG), made a large buy and sell of company shares on November 2, according to a new SEC filing. What Happened: A... 
    Via Benzinga
    Topics Regulatory Compliance
    Exposures Legal Regulatory
    10x Genomics Clocks 74% Jump In Q3 Revenues; Raises Top End Of Sales Guidance
    10x Genomics Inc (NASDAQ: TXG) reported Q3 sales of $125.3 million, beating the consensus of $122.62 million. Sales increased 74% Y/Y, primarily due to increased... 
    Via Benzinga
    10X Genomics Inc (TXG) Q3 2021 Earnings Call Transcript
    TXG earnings call for the period ending September 30, 2021. 
    Via The Motley Fool
    Topics Earnings
    Exposures Financial
    The Daily Biotech Pulse: Cerus Climbs On Earnings, Horizon CFO To Retire, Teva Prices Upsized Sustainability-Linked Senior Note Offering
    Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Horizon Announces Retirement Of CFO, Beat-and-raise Q3 Horizon Therapeutics... 
    Via Benzinga
    Topics Retirement
    Exposures Pension
    Earnings Scheduled For November 3, 2021
    Companies Reporting Before The Bell • R.R.Donnelley & Sons (NYSE:RRD) is likely to report quarterly earnings at $0.32 per share on revenue of $1.19 billion.... 
    Via Benzinga
    Earnings Preview: 10x Genomics
    10x Genomics (NASDAQ:TXG) is set to give its latest quarterly earnings report on Wednesday, 2021-11-03. Here's what investors need to know before the announcement. Analysts... 
    Via Benzinga
    Notable 10X Genomics Insider Trades $2.7M In Company Stock
    Bradford Crutchfield, Chief Commercial Officer at 10X Genomics (NASDAQ:TXG), made a large buy and sell of company shares on October 12, according to a new SEC filing. What... 
    Via Benzinga
    Topics Regulatory Compliance
    Exposures Legal Regulatory
    3 COVID Stocks That Can Turn $1,000 Into $10,000
    Our trio of contributors offer three COVID-19 stocks that will zoom higher, even as we emerge from the pandemic. 
    Via The Motley Fool
    Exposures COVID-19
    Benzinga's Top Ratings Upgrades, Downgrades For September 16, 2021
    Upgrades For Signet Jewelers Ltd (NYSE: 
    Via Benzinga
    The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline
    Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected. Merck & Co, Inc... 
    Via Benzinga
    Why 10x Genomics Shares Are Trading Lower Today
    10x Genomics (NASDAQ:TXG) shares are trading lower after B of A Securities downgraded the stock from Buy to Neutral and announced a $180 price target. 10x Genomics' stock... 
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For September 14, 2021
    Upgrades Northcoast Research upgraded the previous rating for Casey's General Stores Inc ... 
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's After-Market Session
    Gainers Scopus BioPharma (NASDAQ:SCPS) s... 
    Via Benzinga
    Earnings Scheduled For August 5, 2021
    Companies Reporting Before The Bell • OneSpaWorld Holdings (NASDAQ:OSW) is projected to report quarterly loss at $0.20 per share on revenue of $6.42 million. •... 
    Via Benzinga
    Earnings Scheduled For August 4, 2021
    Companies Reporting Before The Bell • UroGen Pharma (NASDAQ:URGN) is projected to report earnings for its second quarter. • Vericel (NASDAQ:VCEL) is expected to... 
    Via Benzinga
    The Daily Biotech Pulse: COVID Disappointments For Altimmune And Angion, Brickell Jumps On Hyperhidrosis Study Updates, 2 IPOs
    Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 29) 10x Genomics, Inc. (NASDAQ... 
    Via Benzinga
    The Daily Biotech Pulse: Orphazyme Falters At FDA, Athira's CEO Placed On Temporary Leave, 5 IPOs
    Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 17) 10x Genomics, Inc. (NASDAQ... 
    Via Benzinga
    Exposures Product Safety
    Stocks That Hit 52-Week Highs On Tuesday
    Tuesday's morning session saw 105 companies set new 52-week highs. Things to Consider: The largest company by market cap to break to a new 52-week high was... 
    Via Benzinga
    Here's Why 10x Genomics Can't Satisfy Short-Term Investors
    Long-term investors should keep perspective. 
    Via The Motley Fool
    10x Genomics Stock Shows Rising Price Performance With Jump To 83 RS Rating
    On Friday, biotech 10x Genomics stock received an upgrade to its Relative Strength (RS) Rating to 83, from 80 on Thursday. 
    Via Investor's Business Daily
    Down More Than 20%, Is This Cathie Wood Biotech A Buy?
    10x Genomics stock has fallen, despite announcing strong first-quarter numbers. 
    Via The Motley Fool
    These 7 Medical Stocks Are Breaking Down — The Sell Rule You Should Know
    Former high-flyers Dexcom and Tandem Diabetes are among seven health care stocks breaking down right now, according to MarketSmith.com. 
    Via Investor's Business Daily
    Earnings Scheduled For May 13, 2021
    Companies Reporting Before The Bell • CASI Pharmaceuticals (NASDAQ:CASI) is estimated to report quarterly loss at $0.06 per share on revenue of $5.05 million. •... 
    Via Benzinga
    < Previous 1 2 3 4 5 6 7 8 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.